Moors & Cabot’s Alkermes ALKS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$305K Sell
7,533
-11
-0.1% -$535 0.01% 760
2026
Q2
$395K Buy
7,544
+427
+6% +$16.7K 0.02% 642
2026
Q1
$252K Buy
+7,117
New +$221K 0.01% 775
2025
Q4
– Sell
-6,777
Closed -$203K – 927
2025
Q3
$203K Buy
+6,777
New +$191K 0.01% 839
2025
Q2
– Sell
-8,604
Closed -$284K – 888
2025
Q1
$284K Sell
8,604
-393
-4% -$12.8K 0.01% 656
2024
Q4
$259K Buy
8,997
+1,028
+13% +$29.6K 0.01% 714
2024
Q3
$223K Buy
+7,969
New +$212K 0.01% 754

Other funds holding ALKS

Moors & Cabot's ALKS Position: Q3 2026 in Review

Moors & Cabot reduced its Alkermes (ALKS) stake by 0.15% in Q3 2026, selling an estimated $535 and leaving 7,533 shares worth $305K. The position accounts for 0.01% of the portfolio, ranked #760.

Moors & Cabot first reported a position in ALKS in Q3 2024 and has held it in 7 quarters since. The position peaked at $395K in Q2 2026. 155 funds tracked by Wall St. Rank hold ALKS as of Q3 2026.

  • Moors & Cabot held 7,533 shares of Alkermes worth $305K as of Q3 2026.
  • Moors & Cabot sold 11 Alkermes shares in Q3 2026, an estimated $535.
  • Alkermes made up 0.01% of Moors & Cabot's portfolio in Q3 2026, its #760 holding.
  • Moors & Cabot first reported a position in Alkermes in Q3 2024 and has held it in 7 quarters since.
  • Moors & Cabot's Alkermes position peaked at $395K in Q2 2026.
  • 155 funds tracked by Wall St. Rank held Alkermes as of Q3 2026.

Based on Moors & Cabot's 13F filing for Q3 2026, filed 6 Nov 2026.